We have an exceptional track record as a pioneer in molecular diagnostics of emerging pathogens and diseases. From developing the world's first rapid genetic SARS testing kit in 2003 to commercialising our in-house EFADchip platform, it is within our DNA to pioneer the next phase of healthcare solutions. EFADchip platform represents the latest revolution of point-of-care diagnostics based on lab-on-a-chip technology.